206 related articles for article (PubMed ID: 27072846)
1. Breaking the gridlock: Regulation of dietary supplements in the United States.
Kapoor A; Sharfstein JM
Drug Test Anal; 2016; 8(3-4):424-30. PubMed ID: 27072846
[TBL] [Abstract][Full Text] [Related]
2. The history of efforts to regulate dietary supplements in the USA.
Swann JP
Drug Test Anal; 2016; 8(3-4):271-82. PubMed ID: 26593452
[TBL] [Abstract][Full Text] [Related]
3. Consumers' perceptions of the dietary supplement health and education act: implications and recommendations.
Dodge T
Drug Test Anal; 2016; 8(3-4):407-9. PubMed ID: 27072844
[TBL] [Abstract][Full Text] [Related]
4. Should states and local governments regulate dietary supplements?
Starr R
Drug Test Anal; 2016; 8(3-4):402-6. PubMed ID: 26594006
[TBL] [Abstract][Full Text] [Related]
5. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
Frankos VH; Street DA; O'Neill RK
Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
[TBL] [Abstract][Full Text] [Related]
6. Label claims for foods and supplements: a review of the regulations.
Turner RE; Degnan FH; Archer DL
Nutr Clin Pract; 2005 Feb; 20(1):21-32. PubMed ID: 16207644
[TBL] [Abstract][Full Text] [Related]
7. The importance of GRAS to the functional food and nutraceutical industries.
Burdock GA; Carabin IG; Griffiths JC
Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
[TBL] [Abstract][Full Text] [Related]
8. Dietary supplements: International legal framework and adulteration profiles, and characteristics of products on the Brazilian clandestine market.
da Justa Neves DB; Caldas ED
Regul Toxicol Pharmacol; 2015 Oct; 73(1):93-104. PubMed ID: 26107294
[TBL] [Abstract][Full Text] [Related]
9. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
Gibson JE; Taylor DA
J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
[TBL] [Abstract][Full Text] [Related]
10. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
11. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
Coppens P; da Silva MF; Pettman S
Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
[TBL] [Abstract][Full Text] [Related]
12. Dietary supplements: What's in a name? What's in the bottle?
Marcus DM
Drug Test Anal; 2016; 8(3-4):410-2. PubMed ID: 27072845
[TBL] [Abstract][Full Text] [Related]
13. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
Saldanha LG
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
[TBL] [Abstract][Full Text] [Related]
14. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
McNamara SH
Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
[No Abstract] [Full Text] [Related]
15. The Basis of Structure/Function Claims of Nutraceuticals.
Borchers AT; Keen CL; Gershwin ME
Clin Rev Allergy Immunol; 2016 Dec; 51(3):370-382. PubMed ID: 27122022
[TBL] [Abstract][Full Text] [Related]
16. The impact of cGMP compliance on consumer confidence in dietary supplement products.
Crowley R; FitzGerald LH
Toxicology; 2006 Apr; 221(1):9-16. PubMed ID: 16469425
[TBL] [Abstract][Full Text] [Related]
17. Dietary Supplements are Not all Safe and Not all Food: How the Low Cost of Dietary Supplements Preys on the Consumer.
Sax JK
Am J Law Med; 2015; 41(2-3):374-94. PubMed ID: 26591824
[TBL] [Abstract][Full Text] [Related]
18. Twenty Years of the Dietary Supplement Health and Education Act--How Should Dietary Supplements Be Regulated?
Wallace TC
J Nutr; 2015 Aug; 145(8):1683-6. PubMed ID: 26063064
[TBL] [Abstract][Full Text] [Related]
19. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update.
McNamara SH
Food Drug Law J; 1996; 51(2):313-8. PubMed ID: 11822323
[No Abstract] [Full Text] [Related]
20. An amphetamine isomer whose efficacy and safety in humans has never been studied, β-methylphenylethylamine (BMPEA), is found in multiple dietary supplements.
Cohen PA; Bloszies C; Yee C; Gerona R
Drug Test Anal; 2016; 8(3-4):328-33. PubMed ID: 25847603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
